NCT00493961View on ClinicalTrials.gov

Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

November 17, 2009

Study Completion Date

November 17, 2009

Conditions
Kallmann SyndromeIdiopathic Hypogonadotropic HypogonadismGnRH Deficiency
Interventions
DRUG

gonadotropin releasing hormone (GnRH)

Pulsatile GnRH (25 ng/kg per bolus every two hours via microinfusion pump)

Trial Locations (1)

02114-2696

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00493961 - Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism | Biotech Hunter | Biotech Hunter